OTC Watch

All stocks / VSEE

VSEE HEALTH, INC. VSEE

VSEE Health (VSEE): shares outstanding up 245% in a year, convertible notes mentioned in an 8-K in September 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.

Costly financingDilutionEstimated float Pink LimitedFlorida, USA
Live quote on OTC Markets

Market listing

Full name
VSEE HEALTH INC
Market tier
OTC Pink Limited
Trading status
Active
Last trade
09:30:04
Website
www.vseehealth.com/
Source: Stockwatch, 2026-11-17

News headlines

VSee Health Announces 13 New Hospital Agreements Expected to Generate More Than $3 Million in Annual Revenue
2026-11-05 09:30 · News Release
VSee Health Shareholder Letter
2026-10-22 09:30 · News Release
VSee Health Poised for Growth
2026-08-27 09:30 · News Release
VSee Enters into Letter of Intent to Acquire Vertically Integrated Healthcare Commerce Platform - Acquisition, Valued at $42Million, Would Add over $35Million in Annualized Revenue and More than $7Million in Earnings
2026-07-30 08:45 · News Release
VSEE Vertically Integrated Healthcare Commerce Platform
2026-07-29 08:30 · News Release
VSee Health Announces Strategic Review as Board Advances Late-Stage Strategic Discussions to Maximize Shareholder Value
2026-07-28 08:30 · News Release
VSee Health Reaffirms Commitment to Minimizing Shareholder Dilution
2026-07-22 08:30 · News Release
VSee Health Vision for AI-Enabled Enterprise Infrastructure as the Next Frontier of Hospital Operations
2026-07-14 09:00 · News Release
VSee Health CEO Issues Shareholder Update as Company Focuses on iDoc TeleHealth Solutions for Revenue Growth and Profitability
2026-07-09 08:45 · News Release
VSee Health Realizes 20X Expansion of its Hospital Network to 58 Locations
2026-06-25 08:30 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Revenue
$14,618,184
Net loss
($14,712,850)
What it means

It spends more than it earns

Under strain

Customers paid it $14.6 million in the year. It lost $14.7 million. For every $1 that came in, about $2.01 went out.

The report says
Cash and cash equivalents
$5,266,286
Net cash used in operating activities
($3,445,733)
What it means

It has cash for a while

Steady

It had $5.3 million in the bank and used about $287,144 a month. At that pace the money lasts about 18 months unless it borrows or sells more shares.

The report says
Total assets
$22,413,019
Total liabilities
$16,960,651
What it means

It owns more than it owes

Steady

Everything the company owns adds up to $22.4 million. Its debts and unpaid bills add up to $17 million. That is about $0.76 owed for every $1 owned.

What this adds up to

1 of 3 checks show strain. It spends more than it earns. These are facts from the company's own reports, not a recommendation.

Signals

Costly financing2026-09-30

8-K filed 2026-09-30 mentions: convertible note.

Rule: 8-K in the last 12 months mentioning convertible notes or an equity line. Source record

Dilution2026-08-12

Shares outstanding rose from 16,422,690 (2025-08-22) to 56,679,813 (2026-08-12), up 245%.

Rule: Shares outstanding up 20% or more in 12 months. Source record

Estimated float2026-08-12

Estimated float about 51,170,642 shares as of 2026-08-12: 56,679,813 outstanding minus 5,509,171 held by 9 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Costly financing2026-07-31

8-K filed 2026-07-31 mentions: convertible note, equity line.

Rule: 8-K in the last 12 months mentioning convertible notes or an equity line. Source record

Costly financing2026-07-24

8-K filed 2026-07-24 mentions: equity line.

Rule: 8-K in the last 12 months mentioning convertible notes or an equity line. Source record

Costly financing2026-07-07

8-K filed 2026-07-07 mentions: convertible note.

Rule: 8-K in the last 12 months mentioning convertible notes or an equity line. Source record

Costly financing2026-06-11

8-K filed 2026-06-11 mentions: equity line.

Rule: 8-K in the last 12 months mentioning convertible notes or an equity line. Source record

Costly financing2026-06-11

8-K filed 2026-06-11 mentions: equity line.

Rule: 8-K in the last 12 months mentioning convertible notes or an equity line. Source record

Shares outstanding

Source: SEC filings
2025-10-14
17.0M
2025-11-14
31.3M
2025-12-31
414,914
2026-03-30
47.3M
2026-03-31
47.3M
2026-05-14
48.6M
2026-06-30
695,998
2026-08-12
56.7M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-10-01 S-1FORM S-1
2026-09-30 8-KFORM 8-K
2026-09-23 8-KFORM 8-K
2026-09-09 8-KFORM 8-K
2026-08-31 8-KFORM 8-K
2026-08-26 8-KFORM 8-K
2026-08-14 SCHEDULE 13G/A
2026-08-14 10-QFORM 10-Q
2026-08-04 8-KFORM 8-K
2026-07-31 8-KFORM 8-K
2026-07-24 8-KFORM 8-K
2026-07-20 DEF 14AFORM DEF 14A

Common questions about VSEE

Does VSEE file reports with the SEC?

Yes. VSEE Health files with the SEC under company number 0001864531. The most recent filing we hold is a S-1 dated 2026-10-01.

Source record

How many VSEE shares are outstanding?

56,679,813 shares as of 2026-08-12, as reported to the SEC. That is up 245% from 16,422,690 on 2025-08-22.

Source record

Has VSEE filed reports late?

We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.

Who runs VSEE Health?

Officers named in its insider filings: Imoigele Aisiku (Co-Chief Executive Officer), Milton Chen (Co-Chief Executive Officer) and Jerry Leonard (Chief Financial Officer).

Source record

Is VSEE Health making money?

Customers paid it $14.6 million in the year. It lost $14.7 million. For every $1 that came in, about $2.01 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record